Early cardiovascular changes occurring in diet-induced, obese insulin-resistant rats

Huisamen, Barbara; Dietrich, Daneel; Bezuidenhout, Nicole; Lopes, John; Flepisi, Brian; Blackhurst, Dee; Lochner, Amanda
September 2012
Molecular & Cellular Biochemistry;Sep2012, Vol. 368 Issue 1/2, p37
Academic Journal
The metabolic syndrome is recognized as a cluster of disturbances associated with obesity, type 2 diabetes and hypertension. Over the past two decades, the number of people with the metabolic syndrome has increased at an alarming rate. This increase is associated with the global epidemic of both obesity and diabetes. Cardiovascular mortality is increased among diabetics and obesity-related insulin-resistant patients, and obesity is currently recognized as independent risk factor for cardiovascular disease. We aimed to establish the effects of a short period of an altered diet on the heart using a rat model of hyperphagia-induced obesity (diet supplemented with sucrose and condensed milk for 8 weeks = DIO) compared to age-matched controls. Isolated, perfused hearts were subjected to global or regional ischaemia/reperfusion. Function on reperfusion was recorded and infarct size determined. A plasma lipid profile was established via HPLC-based methods and proteins involved in metabolic signalling determined either by western blotting or RT-PCR. 8 weeks of diet resulted in whole-body but not myocardial insulin resistance, increased plasma triglyceride and phospholipid levels as well as increased lipid peroxidation. Despite the similar baseline function, hearts from DIO animals showed significantly poorer postischaemic recovery than controls (41.9 % RPP recovery vs 57.9 %, P < 0.05, n = 7-11/group) but surprisingly, smaller infarct size (24.95 ± 1.97 vs 47.26 ± 4.05 % of the area at risk, P < 0.005, n = 8/group). Basal phosphorylation of PKB/Akt was elevated but IRS-1 and SERCA-2 expression severely downregulated. In conclusion, after only 8 weeks of a slight change in diet, the rat heart shows signs of metabolic remodelling. Some of these changes may be protective but others may be detrimental and eventually lead to maladaptation.


Related Articles

  • From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators. Dagdelen, Selcuk // Recent Patents on Endocrine, Metabolic & Immune Drug Discovery;Jan2008, Vol. 2 Issue 1, p24 

    Worldwide epidemic of type 2 diabetes mellitus, obesity, dyslipidemia, hypertension and atherosclerosis (i.e. metabolic syndrome) still requires further treatment strategies. Life style change can be regarded as single evidenced option to manage these co-morbid conditions, at the same time....

  • Metabolic Syndrome. Babb, Michelle // Massage Magazine;Jun2010, Issue 169, p86 

    The article reports on the risk of metabolic syndrome in the U.S. It states that metabolic syndrome occurs when a constellation of risk factors are present that increases the development of type 2 diabetes and cardiovascular disease. The risk factors include insulin resistance, hypertension and...

  • Herkes İçin Bilim; Fruktoz ve Ä°nsan Metabolizması. Korkmaz, Ahmet // TAF Preventive Medicine Bulletin;Jan/Feb2012, Vol. 11 Issue 1, p1 

    Today, metabolic diseases such as type 2 diabetes, hypertension, metabolic syndrome and obesity have been widely affecting the communities. Impressive changes in daily life-style and nutritional habits are well known factors in the etiopathogenesis of those diseases. Fructose (fruit sugar) that...

  • Links between Metabolic Syndrome and Cardiovascular Autonomic Dysfunction. Garruti, G.; Giampetruzzi, F.; Vita, M. G.; Pellegrini, F.; Lagioia, P.; Stefanelli, G.; Bellomo-Damato, A.; Giorgino, F. // Experimental Diabetes Research;2012, Special section p1 

    Background. Type 2 diabetes (T2D) might occur within metabolic syndrome (MbS). One of the complications of T2D is an impaired (imp) cardiovascular autonomic function (CAF). Aims. In subjects with T2D and age ≤ 55 years, the prevalence of impCAF and its relationship with BMI, waist, HbA1c...

  • Glucose Intolerance in Obese Egyptian Adolescents. Azmy, Mohammed K.; Abdel-Monem, Ahmed; Badr, Gamal Ali; Hussein, Moussa Antar; Ghamry, Esam M.; Hablas, Wael Refaat; Abdel-Raouf, Mahmoud Ezzat // Nature & Science;Aug2014, Vol. 12 Issue 8, p25 

    Impaired glucose tolerance (IGT) and Type2 diabetes mellitus (T2DM) in children and adolescents is an important Public Health problem which runs in parallel with childhood obesity. The rates of (IGT) and (T2DM) in youth are increasing recently. The aim of the present study is to assess glucose...

  • Molecular Switch May Hold Key to Cure.  // USA Today Magazine;Oct2006, Vol. 135 Issue 2737, p8 

    The article reports on the way a molecular switch regulates fat and cholesterol production identified by researchers at Harvard University Medical School and Massachusetts General Hospital in Boston. It may help advance treatments for metabolic syndrome, the constellation of diseases that...

  • Metabolic Syndrome Predicts New Onset of Chronic Kidney Disease in 5,829 Patients With Type 2 Diabetes. Luk, Andrea O. Y.; So, Wing-Yee; Ma, Ronald C.W.; Kong, Alice P. S.; Ozaki, Risa; Ng, Vanessa S.W.; Yu, Linda W. L.; Lau, Winnie W.Y.; Xilin Yang; Chow, Francis C. C.; Chan, Juliana C.N.; Tong, Peter C. Y. // Diabetes Care;Dec2008, Vol. 31 Issue 12, p2357 

    OBJECTIVE -- Type 2 diabetes is the leading cause of end-stage renal disease worldwide. Aside from hyperglycemia and hypertension, other metabolic factors may determine renal outcome. We examined risk associations of metabolic syndrome with new onset of chronic kidney disease (CKD) in 5,829...

  • Prevalence of obesity and metabolic syndrome components in Mexican adults without type 2 diabetes or hypertension. Rojas-Martínez, Rosalba; Aguilar-Salinas, Carlos A; Jiménez-Corona, Aída; Gómez-Pérez, Francisco J; Barquera, Simón; Lazcano-Ponce, Eduardo // Salud Pública de México;ene/feb2012, Vol. 54 Issue 1, p7 

    Objective. To describe the number of Mexican adults with undiagnosed diabetes and arterial hypertension and their association with obesity. Material and Methods. The study included a sub-sample of 6 613 subjects aged 20 years or more who participated in the 2006 National Health and Nutrition...

  • Hypertension, obesity and diabetes equals metabolic syndrome. Deas, Gerald W. // New York Amsterdam News;11/5/2009, Vol. 100 Issue 45, p30 

    The article offers health tips to avoid metabolic syndrome and its associated diseases. It reports that the syndrome involves high cholesterol levels, hypertension, and obesity, and mentions the increased risks of type 2 diabetes and kidney and heart diseases in patients suffering from it. It...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics